Triventures

Triventures is a global, early-stage venture capital firm founded in 2010, with offices in Israel and Silicon Valley. The firm invests in innovative companies that converge technology and healthcare to solve critical industry challenges. Triventures manages $200 million in assets and reviews over 700 companies annually, focusing on sectors such as data-driven healthcare, tech-health convergence, and disruptive medical devices​. The Triventures team, led by co-founders Michal Geva and Dr. Peter Fitzgerald, has extensive experience in entrepreneurship and investment, having guided over 30 companies to successful exits. They emphasize partnerships with entrepreneurs to build value-creating companies that reshape healthcare through data-driven solutions and access to significant health data assets, particularly through their collaboration with Sheba Medical Center​. Notable investments include companies like Ginkgo Bioworks, Atomwise, and Verge Genomics, highlighting their focus on pioneering breakthroughs in genomics, synthetic biology, and advanced diagnostics.